449 related articles for article (PubMed ID: 17086058)
1. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
Aberg JA; Price RW; Heeren DM; Bredt B
J Infect Dis; 2002 Apr; 185(8):1179-82. PubMed ID: 11930330
[TBL] [Abstract][Full Text] [Related]
3. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
Negroni R; Helou SH; López Daneri G; Robles AM; Arechavala AI; Bianchi MH
Rev Argent Microbiol; 2004; 36(3):113-7. PubMed ID: 15559192
[TBL] [Abstract][Full Text] [Related]
4. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
[TBL] [Abstract][Full Text] [Related]
5. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
Jongwutiwes U; Sungkanuparph S; Kiertiburanakul S
Jpn J Infect Dis; 2008 Mar; 61(2):111-5. PubMed ID: 18362398
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
8. Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy.
Sheng WH; Hung CC; Chen MY; Hsieh SM; Chang SC
Int J STD AIDS; 2002 Oct; 13(10):702-5. PubMed ID: 12396541
[TBL] [Abstract][Full Text] [Related]
9. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
12. Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Rambeloarisoa J; Batisse D; Thiebaut JB; Mikol J; Mrejen S; Karmochkine M; Kazatchkine MD; Weiss L; Piketty C
J Infect; 2002 Apr; 44(3):185-8. PubMed ID: 12099747
[TBL] [Abstract][Full Text] [Related]
13. [Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].
Alonso M; García F; Mallolas J; Soriano A; Ortega M; Miró JM; Gatell JM; Soriano E
Med Clin (Barc); 1999 Mar; 112(11):401-5. PubMed ID: 10231771
[TBL] [Abstract][Full Text] [Related]
14. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
[TBL] [Abstract][Full Text] [Related]
18. Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole.
Nightingale SD
Arch Intern Med; 1995 Mar; 155(5):538-40. PubMed ID: 7864710
[TBL] [Abstract][Full Text] [Related]
19. Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.
McCarthy KM; Morgan J; Wannemuehler KA; Mirza SA; Gould SM; Mhlongo N; Moeng P; Maloba BR; Crewe-Brown HH; Brandt ME; Hajjeh RA
AIDS; 2006 Nov; 20(17):2199-206. PubMed ID: 17086060
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
